SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for. The Director, US Marketing HCP – TGCT will develop and implement core US marketing launch activities directed at healthcare professionals and drive the commercial strategy for a potential product approval in TGCT. This indication represents a significant opportunity to address an unmet need with patients and treating HCPs. This role will partner across key stakeholders to develop strategy and execute programs and tactics. Reporting into the Senior Director, US TGCT Marketing Lead, the ideal candidate will thrive in a fast-paced environment and demonstrate the ability to independently manage complex deliverables while aligning with brand objectives and working in close partnership with the broader TGCT and rare tumor marketing teams.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
251-500 employees